Literature DB >> 11087753

Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP.

E Shimizu-Sasaki1, M Yamazaki, S Furuyama, H Sugiya, J Sodek, Y Ogata.   

Abstract

Bone sialoprotein (BSP) is a sulfated and phosphorylated glycoprotein, found almost exclusively in mineralized connective tissues, that may function in the nucleation of hydroxyapatite crystals. We have found that expression of BSP in osteoblastic ROS 17/2.8 cells is stimulated by fibroblast growth factor 2 (FGF2), a potent mitogen for mesenchymal cells. Stimulation of BSP mRNA with 10 ng/ml FGF2 was first evident at 3 h ( approximately 2.6-fold) and reached maximal levels at 6 h ( approximately 4-fold). From transient transfection assays, a FGF response element (FRE) was identified (nucleotides -92 to -85, "GGTGAGAA") as a target of transcriptional activation by FGF2. Ligation of two copies of the FRE 5' to an SV40 promoter was sufficient to confer FGF-responsive transcription. A sequence-specific protein-DNA complex, formed with a double-stranded oligonucleotide encompassing the FRE and nuclear extracts from ROS 17/2.8 cells, but not from fibroblasts, was increased following FGF2 stimulation. Several point mutations within the critical FRE sequence abrogated the formation of this complex and suppressed both basal and FGF2-mediated promoter activity. These studies, therefore, have identified a novel FRE in the proximal promoter of the BSP gene that mediates both constitutive and FGF2-induced BSP transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087753     DOI: 10.1074/jbc.M008971200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Effects of interleukin-11 on the expression of human bone sialoprotein gene.

Authors:  Hiroyoshi Matsumura; Yohei Nakayama; Hideki Takai; Yorimasa Ogata
Journal:  J Bone Miner Metab       Date:  2014-03-15       Impact factor: 2.626

2.  Activation of intracellular calcium signaling in osteoblasts colocalizes with the formation of post-yield diffuse microdamage in bone matrix.

Authors:  Hyungjin Jung; Ozan Akkus
Journal:  Bonekey Rep       Date:  2016-03-02

3.  Insulin-like growth factor-II regulates bone sialoprotein gene transcription.

Authors:  Jin Choe; Yoko Sasaki; Liming Zhou; Hideki Takai; Yohei Nakayama; Yorimasa Ogata
Journal:  Odontology       Date:  2015-04-21       Impact factor: 2.634

4.  Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.

Authors:  Gui Xia Zhang; Morimichi Mizuno; Kiyomi Tsuji; Masato Tamura
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

5.  Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts.

Authors:  Sumi Nakao; Yorimasa Ogtata; Emi Shimizu; Muneyoshi Yamazaki; Shunsuke Furuyama; Hiroshi Sugiya
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

Review 6.  Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation.

Authors:  Renny T Franceschi; Guozhi Xiao; Di Jiang; Rajaram Gopalakrishnan; Shuying Yang; Elizabeth Reith
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

7.  The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.

Authors:  Nadiya M Teplyuk; Larisa M Haupt; Ling Ling; Christian Dombrowski; Foong Kin Mun; Saminathan S Nathan; Jane B Lian; Janet L Stein; Gary S Stein; Simon M Cool; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

8.  Expression of osterix Is Regulated by FGF and Wnt/β-Catenin Signalling during Osteoblast Differentiation.

Authors:  Katharina Felber; Philip M Elks; Maria Lecca; Henry H Roehl
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

9.  A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells.

Authors:  Siddaraju V Boregowda; Veena Krishnappa; Christopher L Haga; Luis A Ortiz; Donald G Phinney
Journal:  EBioMedicine       Date:  2015-12-24       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.